Physician profile
Samuel Hakim
NPI 1669509006
$2,360.83
in general payments reported to CMS, 2019-2025
16 companies · $981 in 2025
The $981 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $112 · 2020: $111 · 2021: $54.35 · 2022: $541 · 2023: $204 · 2024: $358 · 2025: $981.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $880 · Travel and Lodging: $663.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $879.98 |
| Travel and Lodging | $662.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,565.58 | 2022-2025 | Altaviva, Interstim, Nuro |
| Janssen Biotech, INC. | $158.45 | 2020-2025 | Erleada, Akeega |
| Axonics, INC. | $141.38 | 2022-2024 | Axonics |
| Sumitomo Pharma America, INC. | $88.44 | 2023-2025 | Gemtesa, Orgovyx |
| Teleflex LLC | $54.35 | 2021 | |
| Tolmar, INC. | $52.61 | 2023-2024 | |
| Boston Scientific Corporation | $46.20 | 2025 | Axonics |
| Urovant Sciences INC | $46.18 | 2022 | |
| Astellas Pharma US INC | $36.38 | 2019 | |
| Pfizer INC. | $35.37 | 2019 | |
| Baxter Healthcare | $28.48 | 2025 | Tisseel |
| Antares Pharma, INC. | $25.27 | 2019 | |
| Myriad Genetic Laboratories, INC. | $24.78 | 2024 | Prolaris |
| Laborie Medical Technologies Corp. | $22.96 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Abbott Laboratories | $19.48 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $14.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Hakim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.